TEST BANK x g
PHARMACOLOGY
CLEAR & SIMPLE:
x g x g
A Guide to Drug Classifications and Dosage Calculations
xg xg xg xg xg xg xg
3RDxg EDITION|xg By:xg Cynthiaxg J.x g Watkins
TEST BANK x g
,TestxgBank:xgPharmacologyxgClearxgandxgSimple:xgAxgGuidexgtoxgDrugxgClassification
sxgandxgDosagexgCalculationsxg3rdxgEditionxgbyxgCynthiaxgJ.xgWatkins
TablexgofxgContents:
Chapterxg1.xgHistoryxgofxgPharmacology
Chapterxg2.xgBasicsxgofxgPharmacology
Chapterxg3.xgPatientxgSafetyxginxgMedicationxgAdministration
Chapterxg4.xgRegulations
Chapterxg5.xgPrescriptionsxgandxgLabels
II.xgCalculations
Chapterxg6.xgBasicxgReviewxgofxgMathemat
icsxgChapterxg7.xgMeasurementxgSystemsx
Chapterxg8.xgDosagexgCalculations
g
Chapterxg9.xgEnteralxgMedicationsxgandxgAdministration
Chapterxg10.xgParenteralxgMedicationsxgandxgAdministration
Chapterxg11.xgIntegumentaryxgSystemxgMedications
Chapterxg12.xgMusculoskeletalxgSystemxgMedications
Chapterxg13.xgNervousxgSystemxgMedications
Chapterxg14.xgEyexgandxgEarxgMedications
Chapterxg15.xgEndocrinexgSystemxgMedications
Chapterxg16.xgCardiovascularxgSystemxgMedications
Chapterxg17.xgImmunologicalxgSystemxgMedications
Chapterxg18.xgPulmonaryxgSystemxgMedications
Chapterxg19.xgGastrointestinalxgSystemxgMedications
Chapterxg20.xgReproductivexgandxgUrinaryxgSystemsxgMedications
Chapterxg21.xgHerbs,xgVitamins,xgandxgMinerals
,Chapterxg1.xgHistoryxg ofxg Pharmacology
PharmacologyxgClearxgandxgSimple-
xgAxgGuidexgtoxgDrugxgClassificationsxgandxgDosagexgCalculationsxg3rdxgEditionxgWatkinsxgTestxgBan
k
1.
Axgnursexgworkingxginxgradiologyxgadministersxgiodinexgtoxgaxgpatientxgwhoxgisxghaving
xgacomputedxgtomographyxg(CT)xgscan.xgThexgnursexgworkingxgonxgthexgoncologyxgunitxg
administersxgchemotherapyxgtoxgpatientsxgwhoxghavexgcancer.xgAtxgthexgPublicxgHealthD
epartment,xgaxgnursexgadministersxgaxgmeasles-mumps-
rubellaxg(MMR)xgvaccinexgtoxgaxg14-month-
oldxgchildxgasxgaxgroutinexgimmunization.xgWhichxgbranchxgofxgpharmacologyxgbestxgdesc
ribesxgthexgactionsxgofxgallxgthreexgnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacologyxgisxgthexgstudyxgofxgthexgbiologicxgeffectsxgofxgchemicals.xgNursesxgarexgi
nvolvedxgwithxgclinicalxgpharmacologyxgorxgpharmacotherapeutics,xgwhichxgisxgaxgbranc
hxgofxgpharmacologyxgthatxgdealsxgwithxgthexgusesxgofxgdrugsxgtoxgtreat,xgprevent,xgandxgd
iagnosexgdisease.xgThexgradiologyxgnursexgisxgadministeringxgaxgdrugxgtoxghelpxgdiagnose
xgaxgdisease.xgThexgoncologyxgnursexgisxgadministeringxgaxgdrugxgtoxghelpxgtreataxgdiseas
e.xgPharmacoeconomicsxgincludesxganyxgcostsxginvolvedxginxgdrugxgtherapy.Pharmacod
ynamicsxginvolvesxghowxgaxgdrugxgaffectsxgthexgbodyxgandxgpharmacokineticsxgisxghowxg
thexgbodyxgactsxgonxgthexgbody.
2.
Axgphysicianxghasxgorderedxgintramuscularxg(IM)xginjectionsxgofxgmorphine
,xgaxgnarcotic,xgeveryxg4xghoursxgasxgneededxgforxgpainxginxgaxgmotorxgvehiclexg
accidentx g victim.xgThexgnursexgisxgawarexgthisxgdrugxghasxgaxghighxgabusexgpo
tential.xgUnderxgwhatxgcategoryxgwouldxgmorphinexgbexgclassified?
A) SchedulexgI
B) SchedulexgII
C) SchedulexgIII
D) SchedulexgIV
Ans: B
, Feedback:
NarcoticsxgwithxgaxghighxgabusexgpotentialxgarexgclassifiedxgasxgSchedulexgIIxgd
rugsxgbecausexgofxgseverexgdependencexgliability.xgSchedulexgIxgdrugsxghavexg
highxgabusexgpotentialx g andx g noxgacceptedxgmedicalx g use.x g Schedulex g IIIx g d
rugsxghavex g ax g lesserxgabusexgpotentialxgthanxgIIxgandxganxgacceptedxgmedicalx
guse.xgSchedulexgIVxgdrugsxghavexglowxgabusexgpotentialxgandxglimitedxgdepen
dencexgliability.
3.
WhenxginvolvedxginxgphasexgIIIxgdrugxgevaluationxgstudies,xgwhatxgrespo
nsibilitiesxgwouldxgthexgnursexghave?
A) Workingxgwithxg animalsxg whoxg arexg givenxg experimentalxg drugs
B) Choosingxgappropriatexg patientsxg toxgbexg involvedxg inxg thexgdrugxg study
C) Monitoringxgandxg observingxg patientsxg closelyxg forxg adversexg effects
D) Conductingxg researchxg toxg determinexg effectivenessxg ofxg thexg drug
Ans: C
Feedback:
PhasexgIIIxgstudiesxginvolvexgusexgofxgaxgdrugxginxgaxgvastxgclinicalxgpopulatio
nxginxgwhichxgpatientsxgarexgaskedxgtoxgrecordxganyxgsymptomsxgtheyxgexperie
ncexgwhilexgtakingxgthexgdrugs.xgNursesxgmayxgbexgresponsiblexgforxghelpingxg
collectxgandxganalyzexgthexginformationxgtoxgbexgsharedxgwithxgthexgFoodxgand
xgDrugxgAdministrationxg(FDA)xgbutxgwouldxgnotxgconductxgresearchxgindepe
ndentlyxgbecausexgnursesxgdoxgnotxgprescribexgmedications.xgUsexgofxganimals
xginxgdrugxgtestingxgisxgdonexginxgthexgpreclinicalxgtrials.xgSelectxgpatientsxgwh
oxgarexginvolvedxginxgphasexgIIxgstudiesxgtoxgparticipatexginxgstudiesxgwherexgt
hexgparticipantsxghavexgthexgdiseasexgthexgdrugxgisxgintendedxgtoxgtreat.xgThese
xgpatientsxgarexgmonitoredxgcloselyxgforxgdrugxgactionxgandxgadversexgeffects.x
gPhasexgIxgstudiesxginvolvexghealthyxghumanxgvolunteersxgwhoxgarexgusuallyxg
paidxgforxgtheirxgparticipation.xgNursesxgmayxgobservexgforxgadversexgeffectsxg
andxgtoxicity.
4.
Whatxgconceptxgisxgconsideredxgwhenxggenericxgdrugsxgarexgsubstitutedxg
forxgbrandxgnamexgdrugs?
A) Bioavailability
B) Criticalx g concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
PHARMACOLOGY
CLEAR & SIMPLE:
x g x g
A Guide to Drug Classifications and Dosage Calculations
xg xg xg xg xg xg xg
3RDxg EDITION|xg By:xg Cynthiaxg J.x g Watkins
TEST BANK x g
,TestxgBank:xgPharmacologyxgClearxgandxgSimple:xgAxgGuidexgtoxgDrugxgClassification
sxgandxgDosagexgCalculationsxg3rdxgEditionxgbyxgCynthiaxgJ.xgWatkins
TablexgofxgContents:
Chapterxg1.xgHistoryxgofxgPharmacology
Chapterxg2.xgBasicsxgofxgPharmacology
Chapterxg3.xgPatientxgSafetyxginxgMedicationxgAdministration
Chapterxg4.xgRegulations
Chapterxg5.xgPrescriptionsxgandxgLabels
II.xgCalculations
Chapterxg6.xgBasicxgReviewxgofxgMathemat
icsxgChapterxg7.xgMeasurementxgSystemsx
Chapterxg8.xgDosagexgCalculations
g
Chapterxg9.xgEnteralxgMedicationsxgandxgAdministration
Chapterxg10.xgParenteralxgMedicationsxgandxgAdministration
Chapterxg11.xgIntegumentaryxgSystemxgMedications
Chapterxg12.xgMusculoskeletalxgSystemxgMedications
Chapterxg13.xgNervousxgSystemxgMedications
Chapterxg14.xgEyexgandxgEarxgMedications
Chapterxg15.xgEndocrinexgSystemxgMedications
Chapterxg16.xgCardiovascularxgSystemxgMedications
Chapterxg17.xgImmunologicalxgSystemxgMedications
Chapterxg18.xgPulmonaryxgSystemxgMedications
Chapterxg19.xgGastrointestinalxgSystemxgMedications
Chapterxg20.xgReproductivexgandxgUrinaryxgSystemsxgMedications
Chapterxg21.xgHerbs,xgVitamins,xgandxgMinerals
,Chapterxg1.xgHistoryxg ofxg Pharmacology
PharmacologyxgClearxgandxgSimple-
xgAxgGuidexgtoxgDrugxgClassificationsxgandxgDosagexgCalculationsxg3rdxgEditionxgWatkinsxgTestxgBan
k
1.
Axgnursexgworkingxginxgradiologyxgadministersxgiodinexgtoxgaxgpatientxgwhoxgisxghaving
xgacomputedxgtomographyxg(CT)xgscan.xgThexgnursexgworkingxgonxgthexgoncologyxgunitxg
administersxgchemotherapyxgtoxgpatientsxgwhoxghavexgcancer.xgAtxgthexgPublicxgHealthD
epartment,xgaxgnursexgadministersxgaxgmeasles-mumps-
rubellaxg(MMR)xgvaccinexgtoxgaxg14-month-
oldxgchildxgasxgaxgroutinexgimmunization.xgWhichxgbranchxgofxgpharmacologyxgbestxgdesc
ribesxgthexgactionsxgofxgallxgthreexgnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacologyxgisxgthexgstudyxgofxgthexgbiologicxgeffectsxgofxgchemicals.xgNursesxgarexgi
nvolvedxgwithxgclinicalxgpharmacologyxgorxgpharmacotherapeutics,xgwhichxgisxgaxgbranc
hxgofxgpharmacologyxgthatxgdealsxgwithxgthexgusesxgofxgdrugsxgtoxgtreat,xgprevent,xgandxgd
iagnosexgdisease.xgThexgradiologyxgnursexgisxgadministeringxgaxgdrugxgtoxghelpxgdiagnose
xgaxgdisease.xgThexgoncologyxgnursexgisxgadministeringxgaxgdrugxgtoxghelpxgtreataxgdiseas
e.xgPharmacoeconomicsxgincludesxganyxgcostsxginvolvedxginxgdrugxgtherapy.Pharmacod
ynamicsxginvolvesxghowxgaxgdrugxgaffectsxgthexgbodyxgandxgpharmacokineticsxgisxghowxg
thexgbodyxgactsxgonxgthexgbody.
2.
Axgphysicianxghasxgorderedxgintramuscularxg(IM)xginjectionsxgofxgmorphine
,xgaxgnarcotic,xgeveryxg4xghoursxgasxgneededxgforxgpainxginxgaxgmotorxgvehiclexg
accidentx g victim.xgThexgnursexgisxgawarexgthisxgdrugxghasxgaxghighxgabusexgpo
tential.xgUnderxgwhatxgcategoryxgwouldxgmorphinexgbexgclassified?
A) SchedulexgI
B) SchedulexgII
C) SchedulexgIII
D) SchedulexgIV
Ans: B
, Feedback:
NarcoticsxgwithxgaxghighxgabusexgpotentialxgarexgclassifiedxgasxgSchedulexgIIxgd
rugsxgbecausexgofxgseverexgdependencexgliability.xgSchedulexgIxgdrugsxghavexg
highxgabusexgpotentialx g andx g noxgacceptedxgmedicalx g use.x g Schedulex g IIIx g d
rugsxghavex g ax g lesserxgabusexgpotentialxgthanxgIIxgandxganxgacceptedxgmedicalx
guse.xgSchedulexgIVxgdrugsxghavexglowxgabusexgpotentialxgandxglimitedxgdepen
dencexgliability.
3.
WhenxginvolvedxginxgphasexgIIIxgdrugxgevaluationxgstudies,xgwhatxgrespo
nsibilitiesxgwouldxgthexgnursexghave?
A) Workingxgwithxg animalsxg whoxg arexg givenxg experimentalxg drugs
B) Choosingxgappropriatexg patientsxg toxgbexg involvedxg inxg thexgdrugxg study
C) Monitoringxgandxg observingxg patientsxg closelyxg forxg adversexg effects
D) Conductingxg researchxg toxg determinexg effectivenessxg ofxg thexg drug
Ans: C
Feedback:
PhasexgIIIxgstudiesxginvolvexgusexgofxgaxgdrugxginxgaxgvastxgclinicalxgpopulatio
nxginxgwhichxgpatientsxgarexgaskedxgtoxgrecordxganyxgsymptomsxgtheyxgexperie
ncexgwhilexgtakingxgthexgdrugs.xgNursesxgmayxgbexgresponsiblexgforxghelpingxg
collectxgandxganalyzexgthexginformationxgtoxgbexgsharedxgwithxgthexgFoodxgand
xgDrugxgAdministrationxg(FDA)xgbutxgwouldxgnotxgconductxgresearchxgindepe
ndentlyxgbecausexgnursesxgdoxgnotxgprescribexgmedications.xgUsexgofxganimals
xginxgdrugxgtestingxgisxgdonexginxgthexgpreclinicalxgtrials.xgSelectxgpatientsxgwh
oxgarexginvolvedxginxgphasexgIIxgstudiesxgtoxgparticipatexginxgstudiesxgwherexgt
hexgparticipantsxghavexgthexgdiseasexgthexgdrugxgisxgintendedxgtoxgtreat.xgThese
xgpatientsxgarexgmonitoredxgcloselyxgforxgdrugxgactionxgandxgadversexgeffects.x
gPhasexgIxgstudiesxginvolvexghealthyxghumanxgvolunteersxgwhoxgarexgusuallyxg
paidxgforxgtheirxgparticipation.xgNursesxgmayxgobservexgforxgadversexgeffectsxg
andxgtoxicity.
4.
Whatxgconceptxgisxgconsideredxgwhenxggenericxgdrugsxgarexgsubstitutedxg
forxgbrandxgnamexgdrugs?
A) Bioavailability
B) Criticalx g concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
